Evidentic GmbH

Evidentic provides clinical-grade molecules, often referred to as secondary standards, as aliquots from original EU- and US-licensed drugs. For early-stage drug development, Evidentic solves a central problem by providing easy access to reference molecules approved by the European Medicine Agency (EMA) and FDA as well as the possibility to procure different batches of drugs that are usually not available on the market at the same time. For researchers in industry and academia, Evidentic provides the cost-efficient option of purchasing clinical grade therapeutic molecules as aliquoted consumables instead of buying expensive original vials.